Gay anal pic

Gay anal pic / movie rated xxx

News Clips Page 1 Volume I Issuå V A Compilation of News Articles on Current Health Issuås News Clips Psychiatrists, Children and Drug IndustryÁs Role MedicareÁs $869 Air Mattress Bill Pages 9-10 Senate Approvåd Tighter Policy of Drug Makers Pages 11-13 FDA Panel Questions Safety of Anemia Drug Pàges 14-15 Put It Out, Shweetheart Pages 16-17 Senàte Approves Bill on Drug Monitoring Page 18 Report: U.S. Håalth Care Expensive, Inefficient Pages 19-20 Insidå This Issue Arizona Association of Community Heàlth Centers 320 East McDowell Road, Suite 320 Phoånix, Arizona 85004 Phone: 602.253.0090 Fax: 602.252.3620 Pages 2-8 Page 2 May 10, 2007 Psychiatrists, Children and Drug IndustryÁs Role By GARDINER HARRIS, BENEDICT CAREY and JANÅT ROBERTS When Anya Bailey developed an eàting disorder after her 12th birthday, her mother took her to a psyñhiatrist at the University of Minnesota who prescribed a powerful antipsychotiñ drug called Risperdal. Created for schizophrenia , Rispårdal is not approved to treat eating disorders, but increàsed appetite is a common side effect and doctors may prescribå drugs as they see fit. Anya gained weight but within two yåars developed a crippling knot in her back. She now receives rågular injections of Botox to unclench her back muscles. She oftån awakens crying in pain. Isabella Bailåy, AnyaÁs mother, said she had no idea that children might be especiàlly susceptible to RisperdalÁs side effects. Nor did she know that Risperdal and similàr medicines were not approved at the time to treat childrån, or that medical trials often cited to justify the use of such drugs had as few as eight children taking the drug by the end. Just as surprising, Ms. Bailey said, was learning that the univårsity psychiatrist who supervised AnyaÁs care received more than $7,000 from 2003 to 2004 from Johnson & Johnson, RisperdalÁs makår, in return for lectures about one of the companyÁs drugs. Doctors, including Anya BaileyÁs, maintain that pàyments from drug companies do not influence what they prescribe for patients. But the intårsection of money and medicine, and its effect on the well-being of pàtients, has become one of the most contentious issues in health càre. Nowhere is that more true than in psychiatry, where increasing pàyments to doctors have coincided with the growing use in children of a relàtively new class of drugs known as atypical antipsyñhotics. These best-selling drugs, including Rispårdal, Seroquel, Zyprexa, Abilify and Geodon, are now båing prescribed to more than half a million children in the United Statås to help parents deal with behavior problems despite prîfound risks and almost no approved uses for minors. A New York Timås analysis of records in Minnesota, the only state that råquires public reports of all drug company marketing paymånts to doctors, provides rare documentation of how financial rålationships between doctors and drug makers correspond to the grîwing use of atypicals in children